Impel Pharmaceuticals (NASDAQ: IMPL)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Impel Pharmaceuticals (NASDAQ: IMPL) through any online brokerage.
The latest price target for Impel Pharmaceuticals (NASDAQ: IMPL) was reported by Guggenheim on Tuesday, May 18, 2021. The analyst firm set a price target for 32.00 expecting IMPL to rise to within 12 months (a possible 252.81% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Impel Pharmaceuticals (NASDAQ: IMPL) is $9.07 last updated June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Impel Pharmaceuticals.
Impel Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Impel Pharmaceuticals.
Impel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.